Updated 25/05/2026
A common endocrine disorder affects up to one in eight women of reproductive age, yet remains undiagnosed in the majority of cases. According to The BMJ, polycystic ovary syndrome (PCOS) has a global prevalence of 7–12%, making it one of the most common hormonal conditions in this population, yet up to 70% of those affected receive no diagnosis.
PCOS Prevalence and Diagnostic Gap: Global Scale
| Metric | Percentage or Range | Population Impact |
|---|---|---|
| Global prevalence of PCOS | 7–12% | Affects 1 in 8–14 women of reproductive age |
| Proportion remaining undiagnosed | Up to 70% | Majority lack clinical recognition and care |
Source: The BMJ, 2024
Systemic Gaps in Diagnosis and Clinical Management
A recent all-party parliamentary group inquiry into PCOS diagnosis, management, and care in the United Kingdom has documented significant systemic failures in how healthcare providers identify and treat the condition. The report, published with endorsement from Verity—the UK’s national PCOS charity—highlights persistent barriers to care.
Up to 70% of people with PCOS remain undiagnosed, reflecting persistent gaps in awareness, recognition, and care across healthcare systems.
— The BMJ, 2024
Clinical Implications and the Role of Metabolic Screening
The condition affects gender diverse people with female sexual organs as well as women of reproductive age, a population often overlooked in traditional screening protocols. Expanding diagnostic awareness to include all at-risk populations is essential for equitable care delivery.
What’s Next: NICE Guidelines and Healthcare Reform
The UK parliamentary inquiry report arrives ahead of updated guidance from the National Institute for Health and Care Excellence (NICE), which is expected to establish standardised diagnostic criteria and management pathways for PCOS across the National Health Service. These guidelines will likely inform clinical practice internationally, as NICE recommendations often influence global health policy.
Key takeaways
- PCOS affects 7–12% of women of reproductive age globally, yet 70% remain undiagnosed according to The BMJ.
- A UK parliamentary inquiry has documented significant systemic failures in PCOS diagnosis and care.
- The report was published with endorsement from Verity, the UK’s national PCOS charity.
- Upcoming NICE guidance is expected to standardise PCOS diagnosis and management across the UK, with potential for global influence on clinical practice and health policy.
Frequently asked questions
What percentage of PCOS cases go undiagnosed?
According to The BMJ, up to 70% of people with PCOS remain undiagnosed, reflecting persistent gaps in awareness, recognition, and care across healthcare systems.
How common is PCOS?
PCOS has a global prevalence of 7-12% among women of reproductive age, making it one of the most common endocrine disorders in this population, according to The BMJ.
What is being done to improve PCOS diagnosis?
The UK has conducted an all-party parliamentary group inquiry into PCOS diagnosis and care, with upcoming NICE guidelines expected to establish standardised diagnostic protocols that may serve as a model for international healthcare systems.
The recognition of PCOS as a common yet under-diagnosed endocrine disorder marks a turning point in clinical practice. The 70% undiagnosed population represents both a public health challenge and an opportunity to prevent complications through earlier intervention. The convergence of parliamentary scrutiny and forthcoming NICE guidance positions the next period as critical for translating clinical evidence into measurable improvements in case identification and quality of care.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
